Abstract: A system for position matching of a patient for medical imaging includes a set of RFID tags configured to locate a patient position. A set of RFID interrogators are located to receive RFID position information from the set of RFID tags. A medical imaging system is positioned to produce a medical image of the patient, where the medical imaging system includes a computer. A patient position calculator receives the RFID position information and calculates a patient position for transmission to the computer.
Type:
Grant
Filed:
September 20, 2007
Date of Patent:
July 26, 2011
Assignee:
Cornell Research Foundation, Inc.
Inventors:
David F. Yankelevitz, Claudia Ingrid Henschke
Abstract: The invention relates to cancer-testis antigens and the nucleic acid molecules that encode them. The invention further relates to the use of the nucleic acid molecules, polypeptides and fragments thereof in methods and compositions for the diagnosis and treatment of diseases, such as cancer. More specifically, the invention relates to the discovery of novel cancer-testis (CT) antigens.
Type:
Application
Filed:
September 8, 2005
Publication date:
July 21, 2011
Applicants:
Ludwig Institute for Cancer Research, Cornell Research Foundation, Inc.
Inventors:
Yao-Tseng Chen, Lloyd J. Old, Andrew J.G. Simpson, Victor C. Jongeneel, Matthew J. Scanlan, Cynthia H. Scanlan
Abstract: The invention provides polymers, methods of preparing polymers, and compositions that include polymers, wherein said polymers include a plurality of two-carbon repeating units in a polymer chain, wherein one or more of the two-carbon repeating units of the polymer chain have a substituent that is covalently bonded to a semifluorinated alkyl ethoxy moiety, and the semifluorinated alkyl ethoxy moiety is attached to the polymer chain substituent through an ester, amide, ketone, carbamate, amine, or other suitable linking group. The polymers can be used to provide antifouling coatings.
Type:
Application
Filed:
February 14, 2011
Publication date:
July 21, 2011
Applicant:
Cornell Research Foundation, Inc.
Inventors:
Christopher K. Ober, Sitaraman Krishnan, Qin Lin
Abstract: The present invention describes a method for identifying one or more of a plurality of sequences differing by one or more single base changes, insertions, deletions, or translocations in a plurality of target nucleotide sequences. The method includes a ligation phase, a capture phase, and a detection phase. The ligation phase utilizes a ligation detection reaction between one oligonucleotide probe, which has a target sequence-specific portion and an addressable array-specific portion, and a second oligonucleotide probe, having a target sequence-specific portion and a detectable label. After the ligation phase, the capture phase is carried out by hybridizing the ligated oligonucleotide probes to a solid support with an array of immobilized capture oligonucleotides at least some of which are complementary to the addressable array-specific portion. Following completion of the capture phase, a detection phase is carried out to detect the labels of ligated oligonucleotide probes hybridized to the solid support.
Type:
Application
Filed:
March 25, 2011
Publication date:
July 21, 2011
Applicant:
CORNELL RESEARCH FOUNDATION, INC.
Inventors:
Francis BARANY, George BARANY, Robert P. HAMMER, Maria KEMPE, Herman BLOK, Monib ZIRVI
Abstract: The present invention relates to a method of treating an inflammatory disorder in a subject with an effective amount of compound having the general formula (I) as described in the present application, under conditions effective to treat the inflammatory disorder. The present invention also relates to a method of inhibiting respiratory burst in neutrophils without inhibiting degranulation in or bacterial killing by the neutrophils by contacting neutrophils with the compounds described above.
Abstract: The invention provides an expression construct comprising a nucleic acid sequence encoding an adeno-associated virus integration efficiency element (AAV IEE), wherein the expression construct is substantially devoid of AAV inverted terminal repeats (AAV ITRs). Such an expression construct site-specifically integrates into a host cell chromosome when provided to a host cell in conjunction with an AAV Rep protein. The invention also provides a method of integrating a nucleic acid sequence of interest into a host cell chromosome through use of such an expression construct, as well as a method of prophylactically or therapeutically treating a mammal for a pathologic state comprising administering to a mammal such an expression construct comprising a nucleic acid sequence encoding a therapeutic factor.
Type:
Application
Filed:
August 24, 2009
Publication date:
July 7, 2011
Applicant:
Cornell Research Foundation, Inc.
Inventors:
Erik S. Falck-Pedersen, Nicola Philpott
Abstract: A method of treating Alzheimer's Disease may include administering to a subject in need of such treatment a CLN2 therapeutic having beta-amyloid degradation activity.
Abstract: A sensor includes a field effect transistor having a source, drain, a control gate and floating gate, wherein the floating gate has an extended portion extending away from the control gate. A sensing gate is capacitively coupled to the extended portion of the floating gate. A polymer electret sensing coating is electrically coupled to the sensing gate.
Type:
Grant
Filed:
September 27, 2007
Date of Patent:
June 14, 2011
Assignee:
Cornell Research Foundation, Inc.
Inventors:
Myongseob Kim, Nick Yu-Min Shen, Chungho Lee, Edwin Chihchuan Kan
Abstract: The subject invention pertains to isolated influenza virus that is capable of infecting canids and causing respiratory disease in the canid. The subject invention also pertains to compositions and methods for inducing an immune response against an influenza virus of the present invention. The subject invention also pertains to compositions and methods for identifying a virus of the invention and diagnosing infection of an animal with a virus of the invention.
Type:
Grant
Filed:
October 19, 2006
Date of Patent:
June 14, 2011
Assignees:
University of Florida Research Foundation, Inc., Cornell Research Foundation, Inc., The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention, Intervet International B.V.
Inventors:
Patti C. Crawford, Paul J. Gibbs, Edward J. Dubovi, Ruben Omar Donis, Jacqueline Katz, Alexander I. Klimov, Nallakannu P. Lakshmanan, Melissa Anne Lum, Daniel Ghislena Emiel Goovaerts, Mark William Mellencamp, Nancy J. Cox, William L. Castleman
Abstract: A load cell for measuring extremely low level, anisotropic biaxial loads is disclosed. The system includes at least one load cell of a specific geometry and dimension which, when mounted, provides a rotationless system accurately transmitting both normal and shearing strains to strain gauges mounted thereon. More specifically, by shaping the load cell so as to concentrate the strains imposed thereon, detection of extremely minute loads, such as coefficients of friction, can be measured.
Abstract: An array of electrochemical detectors includes an array of electrodes that provide current responsive to oxidation events. Each electrode is coupled to a transistor, an amplifier coupled to an input of the transistor and having a feedback loop coupled to the electrode and providing a bias voltage to the electrode, an integrating capacitor coupled to the transistor operable to integrate charge from the electrode, and a reset switch coupled to the integrating capacitor. The amplifier may have a shared stage with other detectors. A shared buffer circuit may also provide a sampled output from multiple detectors.
Type:
Application
Filed:
November 25, 2008
Publication date:
May 26, 2011
Applicant:
Cornell Research Foundation, Inc.
Inventors:
Bradley A. Minch, Sunitha Bandla Ayers, Manfred Lindau
Abstract: The present invention relates to a method of detecting whether a target animal is Bovine Viral Diarrhea Virus (BVDV) positive or negative by determining whether a gp48 protein-specific reagent binds to a gp48 Bovine Viral Diarrhea Virus protein or protein fragment, which retains antigenic specificity, from a target animal's tissue sample.
Type:
Grant
Filed:
October 20, 2008
Date of Patent:
May 24, 2011
Assignees:
Cornell Research Foundation, Inc., IDEXX Laboratories, Inc.
Abstract: The present invention relates to a method of detecting whether a target animal is Bovine Viral Diarrhea Virus (BVDV) positive or negative by determining whether a gp48 protein-specific reagent binds to a gp48 Bovine Viral Diarrhea Virus protein or protein fragment, which retains antigenic specificity, from a target animal's hair sample.
Type:
Grant
Filed:
July 7, 2008
Date of Patent:
May 24, 2011
Assignees:
Cornell Research Foundation, Inc., IDEXX Laboratories
Abstract: Solution blending of masterbatch of cationically functionalized polyvinyl acetate copolymer/silicate nanocomposite where the silicate is substantially exfoliated, and ethylene-vinyl acetate copolymer (EVA), produces product of increased tensile strength and Young's Modulus compared to neat EVA and reduced flammability compared to neat EVA. The product can be injection molded or compression molded or extruded without loss of these advantages.
Abstract: The small molecule profiles of cells are compared to identify small molecules which are modulated in altered states. Cellular small molecule libraries, methods of identifying tissue sources, methods for treating genetic and non-genetic diseases, and methods for predicting the efficacy of drugs are also discussed.
Type:
Grant
Filed:
May 11, 2009
Date of Patent:
May 24, 2011
Assignees:
Metabolon, Inc., Cornell Research Foundation, Inc.
Abstract: The present invention relates to proteasome inhibitors and their use in methods of treating a subject for a pathogen infection or cancer. The methods involve administering to the subject a compound of Formula (I). (I) where: Q is Formula or Formula, where the crossing dashed line illustrates the bond formed joining Q to the rest of the compound of Formula (I). The remainder of substituents of the compound of Formula (I) are defined in the present application.
Abstract: The present invention relates to an article fabrication system having a plurality of material deposition tools containing one or more materials useful in fabricating the article, and a material deposition device having a tool interface for receiving one of the material deposition tools. A system controller is operably connected to the material deposition device to control operation of the material deposition device. Also disclosed is a method of fabricating an article using the system of the invention and a method of fabricating a living three-dimensional structure.
Type:
Grant
Filed:
August 10, 2005
Date of Patent:
May 10, 2011
Assignee:
Cornell Research Foundation, Inc.
Inventors:
Lawrence Bonassar, Hod Lipson, Daniel L. Cohen, Evan Malone
Abstract: High aspect ratio micromachined structures in semiconductors are used to improve power density in Betavoltaic cells by providing large surface areas in a small volume. A radioactive beta-emitting material may be placed within gaps between the structures to provide fuel for a cell. The pillars may be formed of SiC. In one embodiment, SiC pillars are formed of n-type SiC. P type dopant, such as boron is obtained by annealing a borosilicate glass boron source formed on the SiC. The glass is then removed. In further embodiments, a dopant may be implanted, coated by glass, and then annealed. The doping results in shallow planar junctions in SiC.
Type:
Grant
Filed:
December 14, 2009
Date of Patent:
May 10, 2011
Assignee:
Cornell Research Foundation, Inc.
Inventors:
MVS Chandrashekhar, Christopher Ian Thomas, Michael G. Spencer
Abstract: A system and method for detecting mass based on a frequency differential of a resonating micromachined structure, such as a cantilever beam. A high aspect ratio cantilever beam is coated with an immobilized binding partner that couples to a predetermined cell or molecule. A first resonant frequency is determined for the cantilever having the immobilized binding partner. Upon exposure of the cantilever to a solution that binds with the binding partner, the mass of the cantilever beam increases. A second resonant frequency is determined and the differential resonant frequency provides the basis for detecting the target cell or molecule. The cantilever may be driven externally or by ambient noise. The frequency response of the beam can be determined optically using reflected light and two photodetectors or by interference using a single photodetector.
Type:
Grant
Filed:
March 11, 2010
Date of Patent:
May 10, 2011
Assignee:
Cornell Research Foundation, Inc.
Inventors:
Harold G. Craighead, Bojan (Rob) Ilic, David A. Czaplewski, Robert H. Hall
Abstract: The invention relates to three isolated DNA molecules that encode for proteins, BigL1, BigL2 and BigL3, in the Leptospira sp bacterium which have repetitive Bacterial-Ig-like (Big) domains and their use in diagnostic, therapeutic and vaccine applications. According to the present invention, the isolated molecules encoding for BigL1, BigL2 and BigL3 proteins are used for the diagnosis and prevention of infection with Leptospira species that are capable of producing disease in humans and other mammals, including those of veterinary importance.
Type:
Grant
Filed:
March 19, 2010
Date of Patent:
May 3, 2011
Assignees:
The United States of America as represented by the Department of Veterans Affairs, The Regents of the University of California, Cornell Research Foundation, Inc., Fundação Oswaldo Cruz—FIOCRUZ
Inventors:
Albert I. Ko, Mitermayer Galvão Reis, Julio Henrique Rosa Croda, Isadora Cristina Siqueira, David A. Haake, James Matsunaga, Lee W. Riley, Michele Barocchi, Tracy Ann Young